MA27204A1 - Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci - Google Patents

Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci

Info

Publication number: MA27204A1
Authority: MA; Morocco
Prior art keywords: medicament; reagent; preparation; diagnostic; substituted thiophenes
Prior art date: 2002-06-04

Application number

MA27952A

Other languages

English (en)

Inventor

Hans-Jochen Lang

Uwe Heinelt

Armin Hofmeister

Klaus Wirth

Michael Gekle

Markus Bleich

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-04

Filing date

2004-11-16

Publication date

2005-01-03

2004-11-16 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2005-01-03 Publication of MA27204A1 publication Critical patent/MA27204A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)

MA27952A 2002-06-04 2004-11-16 Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci MA27204A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10224892A DE10224892A1 (de)	2002-06-04	2002-06-04	Substituierte Thiophene, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number	Publication Date
MA27204A1 true MA27204A1 (fr)	2005-01-03

Family

ID=29557542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27952A MA27204A1 (fr)	2002-06-04	2004-11-16	Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci

Country Status (32)

Country	Link
EP (1)	EP1513834B1 (fr)
JP (1)	JP4511924B2 (fr)
KR (1)	KR101087966B1 (fr)
CN (1)	CN1324024C (fr)
AR (1)	AR040239A1 (fr)
AT (1)	ATE320425T1 (fr)
AU (1)	AU2003273553B2 (fr)
BR (1)	BR0311548A (fr)
CA (1)	CA2488242C (fr)
CR (1)	CR7577A (fr)
DE (2)	DE10224892A1 (fr)
DK (1)	DK1513834T3 (fr)
EC (1)	ECSP045471A (fr)
ES (1)	ES2258722T3 (fr)
HR (1)	HRP20041153A2 (fr)
IL (1)	IL165519A (fr)
MA (1)	MA27204A1 (fr)
ME (1)	MEP27608A (fr)
MX (1)	MXPA04011986A (fr)
MY (1)	MY129832A (fr)
NO (1)	NO329351B1 (fr)
OA (1)	OA12827A (fr)
PE (1)	PE20040534A1 (fr)
PL (1)	PL372589A1 (fr)
PT (1)	PT1513834E (fr)
RS (1)	RS51141B (fr)
RU (1)	RU2315766C2 (fr)
TN (1)	TNSN04240A1 (fr)
TW (1)	TWI283675B (fr)
UA (1)	UA77551C2 (fr)
WO (1)	WO2003101984A1 (fr)
ZA (1)	ZA200409095B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040242560A1 (en)	2003-05-22	2004-12-02	Aventis Pharma Deutschland Gmbh	Process for synthesizing heterocyclic compounds
DE10323701A1 (de)	2003-05-22	2004-12-23	Aventis Pharma Deutschland Gmbh	Verfahren zur Synthese heterocyclischer Verbindungen
EP1640361B9 (fr)	2003-06-30	2015-11-04	Sumitomo Chemical Company, Limited	Composés d'urée asymétrique et procédé pour la préparation des composés asymétriques par réaction d'addition de conjugue asymétrique en utilisant lesdits composés comme catalyseur
EP2088861A4 (fr) *	2006-10-25	2010-07-07	Takeda Pharmaceutical	Composés de benzimidazole
EP2342178B1 (fr)	2008-09-02	2016-09-28	Sanofi	Aminoindanes substitués et analogues et leur utilisation pharmaceutique
RU2373929C1 (ru) *	2008-11-11	2009-11-27	Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА)	Корректор системы гемостаза, проявляющий ингибирующее действие на адгезивно-агрегационную функцию тромбоцитов для профилактики патологического тромбообразования
WO2011058139A1 (fr) *	2009-11-12	2011-05-19	Selvita Sp. Z O. O.	Composé, procédé pour sa préparation, composition pharmaceutique, utilisation d'un composé, procédé de modulation ou de régulation de serine/thréonine kinases et agent modulateur de sérine/thréonine kinases
RU2518740C1 (ru) *	2013-03-22	2014-06-10	Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ"	СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ДИГИДРОХЛОРИД 2-(3,4-МЕТИЛЕНДИОКСИФЕНИЛ)-9-МОРФОЛИНОЭТИЛИМИДАЗО[1,2-a]БЕНЗИМИДАЗОЛА
ME03311B (fr)	2014-07-25	2019-10-20	Taisho Pharmaceutical Co Ltd	Composé phényl tétrahydroisoquinoléine substitué par un hétéroaryle
KR102840252B1 (ko) *	2023-04-27	2025-07-30	한국화학연구원	시아노벤즈이미다졸 유도체, 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물
WO2025067474A1 (fr) *	2023-09-28	2025-04-03	四川大学华西医院	Composé contenant de la pyridine, son procédé de préparation et son utilisation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE754935A (fr)	1969-08-13	1971-02-17	Hoechst Ag	2-(thienyl-3'-amino)-1,3-diazacycloalcenes et leur preparation
BR6915362D0 (pt) *	1969-08-16	1973-01-04	Hoechst Ag	Processo para a preparacao de 2(tienil-3-amino)1,3-diazacicloalquenos
DE2830279A1 (de) *	1978-07-10	1980-01-31	Boehringer Sohn Ingelheim	2-eckige klammer auf n-(2'-chlor-4'- methyl-thienyl-3')-n-(cyclopropylmethyl)- amino eckige klammer zu-imidazolin-(2), dessen saeureadditionssalze, dieses enthaltende arzneimittel und verfahren zu seiner herstellung
US5395847A (en) *	1993-12-02	1995-03-07	Smithkline Beecham Corporation	Imidazolyl-alkenoic acids
WO2000006169A1 (fr) *	1998-07-29	2000-02-10	Merck & Co., Inc.	Antagonistes des recepteurs de l'integrine
DE19921883A1 (de) *	1999-05-12	2000-11-16	Bayer Ag	Substituierte Thienocycloalk(en)ylamino-1,3,5-triazine
DE19960204A1 (de) *	1999-12-14	2001-06-28	Aventis Pharma Gmbh	Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DK1499311T3 (da) *	2002-03-29	2010-03-08	Novartis Vaccines & Diagnostic	Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer

2002
- 2002-06-04 DE DE10224892A patent/DE10224892A1/de not_active Withdrawn
2003
- 2003-05-26 RU RU2004138812/04A patent/RU2315766C2/ru not_active IP Right Cessation
- 2003-05-26 RS YUP-1038/04A patent/RS51141B/sr unknown
- 2003-05-26 UA UA20041211000A patent/UA77551C2/uk unknown
- 2003-05-26 CN CNB038128462A patent/CN1324024C/zh not_active Expired - Fee Related
- 2003-05-26 JP JP2004509675A patent/JP4511924B2/ja not_active Expired - Fee Related
- 2003-05-26 DE DE50302673T patent/DE50302673D1/de not_active Expired - Lifetime
- 2003-05-26 KR KR1020047019725A patent/KR101087966B1/ko not_active Expired - Fee Related
- 2003-05-26 HR HR20041153A patent/HRP20041153A2/xx not_active Application Discontinuation
- 2003-05-26 DK DK03740148T patent/DK1513834T3/da active
- 2003-05-26 CA CA2488242A patent/CA2488242C/fr not_active Expired - Fee Related
- 2003-05-26 ES ES03740148T patent/ES2258722T3/es not_active Expired - Lifetime
- 2003-05-26 PT PT03740148T patent/PT1513834E/pt unknown
- 2003-05-26 EP EP03740148A patent/EP1513834B1/fr not_active Expired - Lifetime
- 2003-05-26 PL PL03372589A patent/PL372589A1/xx not_active Application Discontinuation
- 2003-05-26 BR BR0311548-8A patent/BR0311548A/pt not_active IP Right Cessation
- 2003-05-26 AU AU2003273553A patent/AU2003273553B2/en not_active Ceased
- 2003-05-26 MX MXPA04011986A patent/MXPA04011986A/es active IP Right Grant
- 2003-05-26 ME MEP-276/08A patent/MEP27608A/xx unknown
- 2003-05-26 AT AT03740148T patent/ATE320425T1/de active
- 2003-05-26 OA OA1200400321A patent/OA12827A/en unknown
- 2003-05-26 WO PCT/EP2003/005465 patent/WO2003101984A1/fr not_active Ceased
- 2003-05-30 PE PE2003000531A patent/PE20040534A1/es not_active Application Discontinuation
- 2003-06-02 AR ARP030101958A patent/AR040239A1/es active IP Right Grant
- 2003-06-02 TW TW092114860A patent/TWI283675B/zh not_active IP Right Cessation
- 2003-06-03 MY MYPI20032052A patent/MY129832A/en unknown
2004
- 2004-11-10 ZA ZA200409095A patent/ZA200409095B/xx unknown
- 2004-11-16 MA MA27952A patent/MA27204A1/fr unknown
- 2004-11-19 CR CR7577A patent/CR7577A/es unknown
- 2004-12-02 IL IL165519A patent/IL165519A/en not_active IP Right Cessation
- 2004-12-02 EC EC2004005471A patent/ECSP045471A/es unknown
- 2004-12-03 TN TNP2004000240A patent/TNSN04240A1/en unknown
- 2004-12-16 NO NO20045504A patent/NO329351B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR101087966B1 (ko)	2011-12-01
CR7577A (es)	2005-06-16
RS51141B (sr)	2010-10-31
MY129832A (en)	2007-05-31
DK1513834T3 (da)	2006-07-17
RU2004138812A (ru)	2005-07-20
HRP20041153A2 (en)	2005-06-30
MEP27608A (en)	2010-06-10
EP1513834B1 (fr)	2006-03-15
JP4511924B2 (ja)	2010-07-28
MXPA04011986A (es)	2005-03-07
AU2003273553B2 (en)	2008-12-04
PE20040534A1 (es)	2004-10-25
UA77551C2 (en)	2006-12-15
TW200406409A (en)	2004-05-01
CA2488242C (fr)	2011-08-02
CN1324024C (zh)	2007-07-04
AR040239A1 (es)	2005-03-23
PT1513834E (pt)	2006-06-30
ECSP045471A (es)	2005-01-28
RU2315766C2 (ru)	2008-01-27
DE50302673D1 (de)	2006-05-11
CA2488242A1 (fr)	2003-12-11
KR20050005532A (ko)	2005-01-13
WO2003101984A1 (fr)	2003-12-11
IL165519A (en)	2010-05-31
TNSN04240A1 (en)	2007-03-12
DE10224892A1 (de)	2003-12-18
NO20045504L (no)	2005-01-25
CN1659163A (zh)	2005-08-24
IL165519A0 (en)	2006-01-15
PL372589A1 (en)	2005-07-25
ZA200409095B (en)	2005-05-10
BR0311548A (pt)	2005-04-12
TWI283675B (en)	2007-07-11
HK1076460A1 (en)	2006-01-20
EP1513834A1 (fr)	2005-03-16
OA12827A (en)	2006-07-11
ES2258722T3 (es)	2006-09-01
ATE320425T1 (de)	2006-04-15
AU2003273553A1 (en)	2003-12-19
RS103804A (sr)	2006-12-15
JP2005533038A (ja)	2005-11-04
NO329351B1 (no)	2010-10-04

Publication	Publication Date	Title
BR9605417A (pt)	1998-08-04	Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
MA27147A1 (fr)	2005-01-03	4-phenyltetrahydro-isoquinoleines substituees, procede pour leur preparation, leur utilisation en tant que medicament, et medicament les contenant
MXPA03005018A (es)	2003-09-25	Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos, y su uso.
MXPA03005019A (es)	2003-09-25	Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos y su uso.
DE69934773D1 (de)	2007-02-22	Vorrichtung zur Verabreichung von Medikamenten
MA27204A1 (fr)	2005-01-03	Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci
MA27252A1 (fr)	2005-03-01	Diphenylazetidinones substituees, leur procede de preparation, medicaments contenant ces composes et leur utilisation
EP1688392A4 (fr)	2011-06-08	Tamis moleculaire a structure mfi contenant des composants phosphores et metalliques, procede de preparation et d'utilisation de ce dernier
MXPA02004119A (es)	2003-10-06	Nuevos ciclopropanos como antagonistas de cgrp, medicamentos que contienen estos compuestos y metodo para obtencion de los mismos.
PL356235A1 (en)	2004-06-28	Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
ATE337317T1 (de)	2006-09-15	Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
IL165213A0 (en)	2005-12-18	Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilizationmedicament or diagnostic agent and medicament containing same
IL173843A0 (en)	2006-07-05	Assay for coronaviruses, reagents for use therein and kits containing the same
NO972433L (no)	1997-12-01	Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
TR199600400A2 (tr)	1997-03-21	Ikame edilmis benziloksikarbonil-guanidinler, bunlarin elde edilmesine iliskin yöntem, ilac veya teshis maddesi olarak kullanilmasi veya bu maddeleri ihtiva eden ilaclar.
BR0011586B1 (pt)	2008-11-18	processo e dispositivo para a fabricaÇço de um produto a partir de uma fita adesiva, em particular um produto que contÉm uma substÂncia ativa e/ou medicinal.
NO954739D0 (no)	1995-11-23	Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene
NO983577D0 (no)	1998-08-04	Sulfonamidsubstituerte forbindelser, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen
BR9605568A (pt)	1998-08-18	Benzoilguanidinas substituídas por sulfonilamino processo para a sua preparaçao seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
NO972434D0 (no)	1997-05-28	Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
DK1129208T3 (da)	2003-02-10	Vancoresmycin, fremgangsmåde til dets fremstilling samt dets anvendelse som farmaceutisk middel
ATE406211T1 (de)	2008-09-15	Einweg-fraktioniervorrichtung
MA27149A1 (fr)	2005-01-03	Les imidazolidines substitues,la methode de leur production,leur utilisation comme un medicament ou comme un moyen de diagnostique et le medicament qui contient les imidazolidines substitues
MA27171A1 (fr)	2005-01-03	Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substances
ID17321A (id)	1997-12-18	Orto-benzoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya.